Inventor · disambiguated record
Utpal Pajvani
Also filed as: PAJVANI UTPAL · PAJVANI UTPAL B
2 granted patents·10 pending applications·0 citations·filing 2004–2023
29Inventor score
Top patents by PatentIndex Score
12 records- 0150US2023201128A1Method of treating obesity-induced glucose intolerance and liver fibrosisUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 0249US2023172965A1Targeting ltbp3 for nonalcoholic steatohepatitis (nash)-induced liver fibrosisUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 0349US2023241093A1Targeting adispsin for nonalcoholic steatohepatitis (nash)- induced liver fibrosisUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 0447US2019125829A1Method for preventing obesity-induced fatty liver by inhibiting kctd17UNIV COLUMBIA·Filed 2017·Application pending·0 cites
- 0546US2018303901A1Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty LiverPAJVANI UTPAL·Filed 2018·Application pending·0 cites
- 0643US10801068B2JAG1 expression predicts therapeutic response in NASHPAJVANI UTPAL·Filed 2016·Granted Oct 13, 2020·0 cites·14 claims
- 0743US2021025003A1Jag1 expression predicts therapeutic response in nashPAJVANI UTPAL·Filed 2020·Application pending·0 cites
- 0840US10149855B2Gamma-secretase inhibition reduce APOC3 levels and plasma triglyceridesPAJVANI UTPAL·Filed 2015·Granted Dec 11, 2018·0 cites·19 claims
- 0940US2017014477A1Free raptor reduces aging- and obesity-induced fatty liverPAJVANI UTPAL·Filed 2016·Application pending·0 cites
- 1039US2019091234A1Gamma-secretase inhibition reduce apoc3 levels and plasma triglyceridesPAJVANI UTPAL·Filed 2018·Application pending·0 cites
- 1138US2016030513A1Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty LiverPAJVANI UTPAL·Filed 2015·Application pending·0 cites
- 1234US2007098636A1Method of identifying responders to treatment with insulin sensitizersWAGNER JOHN A·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Utpal Pajvani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →